Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	34	non-cytoplasmic
35	54	transmembrane
55	88	cytoplasmic
89	111	transmembrane
112	131	non-cytoplasmic
132	161	transmembrane
162	172	cytoplasmic
173	197	transmembrane
198	207	non-cytoplasmic
208	233	transmembrane
234	254	cytoplasmic
255	277	transmembrane
278	282	non-cytoplasmic
283	302	transmembrane
303	313	cytoplasmic
314	334	transmembrane
335	353	non-cytoplasmic
354	372	transmembrane
373	377	cytoplasmic
378	397	transmembrane
398	406	non-cytoplasmic
407	434	transmembrane
435	446	cytoplasmic
447	476	transmembrane
477	482	non-cytoplasmic

Input:
>3610014
MFLLEALGQFMTLNEFAVLAMFLVFIYLLFRGIPVAYALVGVSLIFALVAEIFLDPNRAA
FRDIIEFDRTGIDYQRLQVLSGRLFGNIVKNPVLVALPMFIFMGLMLDQSGVAQRMMHSM
QKLFGGLRGGLSLTVMLIGIILAASTGVIGASVTLLGVMALPAMMQQNYSKPIATGTIAS
AGTLGILIPPSIMLVIMSDQLAISLGDLFMGALFPGLILGALYIIFIIAYGLINPKAMPA
PPQTDEVGWDVVKDVLLAVVPPMFLILLVLGSIFAGFATPTEASGLGALGATLLALANGR
LNFKVLKEVSRSTLNTSGYIVGIFLAANFFALVLRRYGGDEIIQGYVLSTFSDPYMIVLF
ILFIIFLLGFLLDWIEITIIIMPLMLPIIVGLDLAVPGFDQVRDPAVVWFAILVAVTLQT
SFLTPPVGFALFYLKGVCPPGVSLGHIYKGIIPFVMLQLLGLFIVFQFPALTTWLPAIAY
AD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server